Modelling the cost effectiveness of rapid point of care diagnostic tests for the control of HIV and other sexually transmitted infections among female sex workers

Background: In sub-Saharan Africa, gonococcal and chlamydial infections are usually managed using the syndromic approach. However, many infections are asymptomatic in women, and the syndromic algorithm has poor sensitivity and specificity for infections caused by Neisseria gonorrhoeae (Ng) and Chlamydia trachomatis (Ct). Because of this, rapid point of care (POC) tests for Ct/Ng could improve sexually transmitted infection (STI) management in women. This study uses mathematical modelling to estimate the incremental cost effectiveness of using POC tests to diagnose Ng/Ct instead of the current syndromic approach used by the SIDA2 HIV/STI prevention project for female sex workers in Cotonou, Benin. Methods: A dynamic mathematical model was used with data from Cotonou to estimate the HIV impact of the existing SIDA2 project (1995–8), and to project how impact would change if POC tests had been used. As observed in test evaluations, the POC tests were assumed to have high specificity, but a range of sensitivities. The incremental economic cost effectiveness of using POC tests was modelled using data on intervention costs and an evaluation of an Ng POC test in Cotonou in 2004. All costs were in 2004 $US. Results: The model estimated the STI treatment aspect of the intervention averted 18 553 Ng/Ct and 359 HIV infections over 4 years when the syndromic approach was used. In contrast, if Ng/Ct had been diagnosed with a 70–80% sensitive and 95% specific POC test then 24–31% fewer clinic attenders would have been treated, 40–60% more Ng/Ct and HIV infections would have been averted, and the incremental cost effectiveness of using them would have been $107–151 per HIV infection averted if the POC tests cost $2 and $58–$81 if they cost $1. Conclusions: POC tests can be a cost effective strategy for substantially increasing the impact on HIV transmission, and decreasing the degree of inappropriate treatment of STI treatment interventions that use syndromic management to diagnose Ng/Ct.

[1]  C. Watts,et al.  The Cost-Effectiveness of Expanding Harm Reduction Activities for Injecting Drug Users in Odessa, Ukraine , 2006, Sexually transmitted diseases.

[2]  H. Rees,et al.  The Importance of Context: Model Projections on How Microbicide Impact Could Be Affected by the Underlying Epidemiologic and Behavioral Situation in 2 African Settings , 2006, Sexually transmitted diseases.

[3]  John W Tapsall,et al.  Antibiotic resistance in Neisseria gonorrhoeae. , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[4]  R. Peeling,et al.  Sensitivity requirements for the point of care diagnosis of Chlamydia trachomatis and Neisseria gonorrhoeae in women , 2003, Sexually transmitted infections.

[5]  Margaret-Mary G. Wilson,et al.  Sexually transmitted diseases. , 2003, Clinics in geriatric medicine.

[6]  M. Alary,et al.  Syndromic Versus Laboratory-Based Diagnosis of Cervical Infections Among Female Sex Workers in Benin: Implications of Nonattendance for Return Visits , 2002, Sexually transmitted diseases.

[7]  J. Vessey,et al.  The Role of Disease-Specific Infectivity and Number of Disease Exposures on Long-Term Effectiveness of the Latex Condom , 2002, Sexually transmitted diseases.

[8]  K. Floyd,et al.  Cost-effectiveness of HIV/AIDS interventions in Africa: a systematic review of the evidence , 2002, The Lancet.

[9]  M. Alary,et al.  Role of core and bridging groups in the transmission dynamics of HIV and STIs in Cotonou, Benin, West Africa , 2002, Sexually transmitted infections.

[10]  M. Boily,et al.  The impact of HIV epidemic phases on the effectiveness of core group interventions: insights from mathematical models , 2002, Sexually transmitted infections.

[11]  C. Mahé,et al.  HIV-1 infection in rural Africa: is there a difference in median time to AIDS and survival compared with that in industrialized countries? , 2002, AIDS.

[12]  M. Alary,et al.  Decline in the prevalence of HIV and sexually transmitted diseases among female sex workers in Cotonou, Benin, 1993–1999 , 2002, AIDS.

[13]  Ronald H Gray,et al.  What proportion of episodes of gonorrhoea and chlamydia becomes symptomatic? , 2002, International journal of STD & AIDS.

[14]  C. Mahé,et al.  Progression to symptomatic disease in people infected with HIV-1 in rural Uganda: prospective cohort study. , 2002, BMJ.

[15]  G. Corbitt,et al.  Is there any role for rapid tests for Chlamydia trachomatis? , 2002, International journal of STD & AIDS.

[16]  J. Habbema,et al.  Estimating the Magnitude of STD Cofactor Effects on HIV Transmission: How Well Can it Be Done? , 2001, Sexually transmitted diseases.

[17]  G. Garnett,et al.  A Systematic Review of the Epidemiologic Interactions Between Classic Sexually Transmitted Diseases and HIV: How Much Really Is Known? , 2001, Sexually transmitted diseases.

[18]  R. Hayes,et al.  Commercial sex and the spread of HIV in four cities in sub-Saharan Africa , 2001, AIDS.

[19]  R. Hayes,et al.  The multicentre study on factors determining the differential spread of HIV in four African cities: summary and conclusions , 2001, AIDS.

[20]  R. Hayes,et al.  The epidemiology of gonorrhoea, chlamydial infection and syphilis in four African cities , 2001, AIDS.

[21]  E. Lagarde,et al.  Male circumcision and HIV infection in four cities in sub-Saharan Africa , 2001, AIDS.

[22]  B Ferry,et al.  Comparison of key parameters of sexual behaviour in four African urban populations with different levels of HIV infection , 2001, AIDS.

[23]  G. Maartens,et al.  AIDS in Africa--survival according to AIDS-defining illness. , 2001, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.

[24]  S. Vermund,et al.  Virologic and immunologic determinants of heterosexual transmission of human immunodeficiency virus type 1 in Africa. , 2001, AIDS research and human retroviruses.

[25]  J. Hopwood,et al.  Evaluation of near patient testing for Chlamydia trachomatis in a pregnancy termination service , 2001, Journal of Family Planning and Reproductive Health Care.

[26]  P. Sen,et al.  Viral burden in genital secretions determines male-to-female sexual transmission of HIV-1: a probabilistic empiric model , 2001, AIDS.

[27]  M. Alary,et al.  Management of sexually transmitted diseases and HIV prevention in men at high risk: targeting clients and non-paying sexual partners of female sex workers in Benin , 2000, AIDS.

[28]  R. Hayes,et al.  Male circumcision and risk of HIV infection in sub-Saharan Africa: a systematic review and meta-analysis , 2000, AIDS.

[29]  L. Kumaranayake,et al.  The real and the nominal? Making inflationary adjustments to cost and other economic data. , 2000, Health policy and planning.

[30]  T. Quinn,et al.  Viral load and heterosexual transmission of human immunodeficiency virus type 1. Rakai Project Study Group. , 2000, The New England journal of medicine.

[31]  E. Hook,et al.  The rapid test paradox: when fewer cases detected lead to more cases treated: a decision analysis of tests for Chlamydia trachomatis. , 1999, Sexually transmitted diseases.

[32]  M. Wawer,et al.  Asymptomatic non-ulcerative genital tract infections in a rural Ugandan population. , 1998, Sexually transmitted infections.

[33]  S. Pinkerton,et al.  Updated estimates of condom effectiveness. , 1998, The Journal of the Association of Nurses in AIDS Care : JANAC.

[34]  M. Alary,et al.  Evaluation of clinical algorithms for the diagnosis of gonococcal and chlamydial infections among men with urethral discharge or dysuria and women with vaginal discharge in Benin. , 1998, Sexually transmitted infections.

[35]  I. Hoffman,et al.  Validation of the WHO diagnostic algorithm and development of an alternative scoring system for the management of women presenting with vaginal discharge in Malawi. , 1998, Sexually transmitted infections.

[36]  S. Kapiga,et al.  Evaluation of sexually transmitted diseases diagnostic algorithms among family planning clients in Dar es Salaam, Tanzania. , 1998, Sexually transmitted infections.

[37]  D. Goldberg,et al.  HIV infection among family planning clinic attenders in Glasgow: why prevalence has remained low in this general population group. , 1998, Sexually transmitted infections.

[38]  P. Garred Chemokine-receptor polymorphisms: clarity or confusion for HIV-1 prognosis? , 1998, The Lancet.

[39]  S. Pinkerton,et al.  Effectiveness of condoms in preventing HIV transmission. , 1997, Social science & medicine.

[40]  R. Royce,et al.  Sexual transmission of HIV. , 1997, The New England journal of medicine.

[41]  R. Anderson,et al.  The Natural History of Syphilis: Implications for the Transmission Dynamics and Control of Infection , 1997, Sexually transmitted diseases.

[42]  M. Alary,et al.  Evaluation of a Screening Algorithm for the Diagnosis of Genital Infections With Neisseria gonorrhoeae and Chlamydia trachomatis Among Female Sex Workers in Bénin , 1997, Sexually transmitted diseases.

[43]  T. Quinn,et al.  Epidemiologic and microbiologic correlates of Chlamydia trachomatis infection in sexual partnerships. , 1996, JAMA.

[44]  J. Todd,et al.  Impact of improved treatment of sexually transmitted diseases on HIV infection in rural Tanzania: randomised controlled trial , 1995, The Lancet.

[45]  T. Quinn,et al.  Use of cell culture and a rapid diagnostic assay for Chlamydia trachomatis screening. , 1994, JAMA.

[46]  Hadi Dowlatabadi,et al.  Sensitivity and Uncertainty Analysis of Complex Models of Disease Transmission: an HIV Model, as an Example , 1994 .

[47]  P. Piot,et al.  Clinical algorithms for the screening of women for gonococcal and chlamydial infection: evaluation of pregnant women and prostitutes in Zaire. , 1993, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[48]  Dean T. Jamison,et al.  World development report 1993 : investing in health , 1993 .

[49]  Kkk Comparison of female to male and male to female transmission of HIV in 563 stable couples. European Study Group on Heterosexual Transmission of HIV. , 1992, BMJ.

[50]  G. Ruijs,et al.  Prevalence, incidence, and risk of acquiring urogenital gonococcal or chlamydial infection in prostitutes working in brothels. , 1988, Genitourinary medicine.

[51]  E. Lycke,et al.  The Risk of Transmission of Genital Chlamydia trachomatis Infection Is Less than That of Genital Neisseria gonorrhoeae Infection , 1980, Sexually transmitted diseases.

[52]  K. Holmes,et al.  Cohort study of venereal disease. I: the risk of gonorrhea transmission from infected women to men. , 1978, American journal of epidemiology.

[53]  K. Holmes,et al.  An estimate of the risk of men acquiring gonorrhea by sexual contact with infected females. , 1970, American journal of epidemiology.

[54]  H. Hanschell SULPHANILAMIDE IN THE TREATMENT OF CHANCROID , 1938 .

[55]  C. D. Da Ros,et al.  Global epidemiology of sexually transmitted diseases. , 2008, Asian journal of andrology.

[56]  R. Peeling,et al.  Detection of gonococcal infection : pros and cons of a rapid test. , 2005, Molecular diagnosis : a journal devoted to the understanding of human disease through the clinical application of molecular biology.

[57]  R. Harding,et al.  XV International AIDS Conference , 2004 .

[58]  M. Kretzschmar,et al.  Comparative model-based analysis of screening programs for Chlamydia trachomatis infections. , 2001, American journal of epidemiology.

[59]  C. Watts,et al.  Violence against women: its importance for HIV/AIDS. , 2000, AIDS.

[60]  Alan D. Lopez,et al.  Health dimensions of sex and reproduction : the global burden of sexually transmitted diseases, HIV, maternal conditions, perinatal disorders, and congenital anomalies , 1998 .

[61]  BOMBAY CALCUrIA,et al.  World development report 1993--investing in health. , 1993, Communicable disease report. CDR weekly.

[62]  Johnson Comparison of female to male and male to female transmission of HIV in 563 stable couples. European Study Group on Heterosexual Transmission of HIV , 1992 .